Press Release

CAR-T Cell Therapy Market to Register Healthy Growth through 2025

Increasing prevalence of cancer and widespread research activities to drive global CAR-T cell therapy market

According to TechSci Research report, Global CAR-T Cell Therapy Market By Indication (Diffused Large B-cell Lymphoma (DLBCL), Acute Lymphoblastic Leukemia (ALL), Multiple Myeloma (MM), Chronic Lymphocytic Leukemia (CLL), Follicular Lymphoma (FL), Others), By Targeted Antigen(CD 19, CD22, BCMA (B-Cell Maturation Antigen), HER1, HER2, Meso, EGFRvlll, Others), By Product Type (Yescarta (Axicabtagene Ciloleucel), Kymriah (Tisagenlecleucel), JCAR017 (Lisocabtagene Maraleucel), bb2121), By End User (Hospitals, Cancer Treatment Centers, Others), By Region, Forecast & Opportunities, 2025, the market is anticipated to grow at a robust CAGR during the forecast period. Key factors fueling the growth of global CAR-T cell therapy market include rising prevalence of cancer around the globe and increasing need for breakthrough therapeutic solutions. There is an increasing number of patients who are showing response failure to alternative treatments. This factor is also expected to foster the growth of global CAR-T cell therapy market in the coming years. Moreover, rising R&D expenditure and boom in the field of immuno-oncology are some other factors propelling the growth of this market. Also, rising government initiatives for promoting research for cell therapy in cancer and improving health care infrastructure are supporting the growth of global CAR-T cell therapy market.

Additionally, increasing clinical trials and development of new and effective therapy options are driving the growth of this market. The effectiveness of CAR-T cell therapy in treating cancer is anticipated to present huge growth opportunities for pharmaceutical and biotech companies. However, the market might also face some restrains. The complicated manufacturing process of CAR-T cells and high cost of the treatment might hamper the market growth. Furthermore, side effects of CAR-T cell therapy may lead to neurological problems and cytokine release syndrome (CRS). This factor also might pose as a challenge for the growth of global CAR-T cell therapy market.

Browse XX market data Tables and XX Figures spread through XXX Pages and an in-depth TOC on "Global CAR-T Cell Therapy Market"

https://www.techsciresearch.com/report/car-t-cell-therapy-market/5168.html

The global CAR-T cell therapy market is segmented based on indication, targeted antigen, product type, end user and region. Based on targeted antigen, the market can be segmented into CD 19, CD22, BCMA (B-Cell Maturation Antigen), HER1, HER2, Meso, EGFRvlll and others. Among them, CD 19 antigen is expected to hold largest market share during the forecast period as more companies are able to get their CD 19 antigens approved and have them commercialized. However, B-Cell Maturation Antigen (BCMA) is anticipated to witness fastest CAGR through 2025 as they play a critical role in regulating B-cell proliferation and survival.

Based on indication, global CAR-T cell therapy market can be segmented into Diffused Large B-cell Lymphoma (DLBCL), Acute Lymphoblastic Leukemia (ALL), Multiple Myeloma (MM), Chronic Lymphocytic Leukemia (CLL), Follicular Lymphoma (FL) and others. Among them, Diffused Large B-cell Lymphoma (DLBCL) segment is expected to witness high growth during the forecast period as it is one of the most common types of non-Hodgkin lymphoma around the world.

Major players operating in the global CAR-T cell therapy market include Kite Pharma (subsidiary of Gilead Sciences), AbbVie Inc., Bluebird Bio, Bristol Myers Squibb (BMS), Gilead Sciences, Inc., Cellectis, Servier Laboratories, Pfizer Inc., Merck KGaA, Juno Therapeutics, Amgen Inc., Intellia Therapeutics, Novartis International AG, Caribou Biosciences, Inc., Celyad, Bellicum Pharmaceuticals, Inc., Noile-Immune Biotech, Cartesian Therapeutics, Johnson & Johnson and Sangamo Therapeutics, Inc. The companies are undergoing extensive research & development activities to launch new targeted cell therapies in the market.

Download Sample Report @ https://www.techsciresearch.com/sample-report.aspx?cid=5168

Customers can also request for 10% free customization on this report.

“North America dominated the global CAR-T cell therapy market in 2019 and is expected to hold its dominance through 2025 owing to large patient pool suffering from cancer in countries such as United States and Canada. Also, rapid development and launch of new therapies for the treatment of cancer by leading companies is making the region a profitable market for manufactures. Following North America, Europe is anticipated to be the second most prominent market for CAR-T cell therapy due to extensive research for development of cancer therapies in the region,” said Mr. Karan Chechi, Research Director with TechSci Research, a research based global management consulting firm.

Global CAR-T Cell Therapy Market By Indication (Diffused Large B-cell Lymphoma (DLBCL), Acute Lymphoblastic Leukemia (ALL), Multiple Myeloma (MM), Chronic Lymphocytic Leukemia (CLL), Follicular Lymphoma (FL), Others), By Targeted Antigen(CD 19, CD22, BCMA (B-Cell Maturation Antigen), HER1, HER2, Meso, EGFRvlll, Others), By Product Type (Yescarta (Axicabtagene Ciloleucel), Kymriah (Tisagenlecleucel), JCAR017 (Lisocabtagene Maraleucel), bb2121), By End User (Hospitals, Cancer Treatment Centers, Others), By Region, Forecast & Opportunities, 2025” has evaluated the future growth potential of global CAR-T cell therapy market and provides statistics & information on market size, structure and future market growth. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment decisions. Besides, the report also identifies and analyzes the emerging trends along with essential drivers, challenges and opportunities in global CAR-T cell therapy market.

Contact

Mr. Ken Mathews

708 Third Avenue,

Manhattan, NY,

New York – 10017

 

Tel: +1-646-360-1656

 

Email: sales@techsciresearch.com

Relevant News